4//SEC Filing
MERRIFIELD C ANN 4
Accession 0000950170-25-073611
CIK 0001327273other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:30 PM ET
Size
5.5 KB
Accession
0000950170-25-073611
Insider Transaction Report
Form 4
MERRIFIELD C ANN
Director
Transactions
- Award
Restricted Stock Units
2025-05-14+32,000→ 32,000 total→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001247224
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:30 PM ET
- Size
- 5.5 KB